High SHBG With High Testosterone: What the Pattern Means and How to Measure It Properly

Oak
shbg testosterone hormones biomarkers endocrinology
Studio-lit black four-winged reptile specimen with a translucent throat sac holding amber droplets trapped in a lattice, a few glowing free.

High SHBG with high total testosterone is usually one finding, not two. Sex hormone-binding globulin (SHBG) is the liver-made carrier protein that holds roughly 40 to 60 percent of circulating testosterone in a high-affinity bond, and total testosterone assays measure bound and unbound hormone together. When SHBG goes up, the reservoir of bound hormone goes up, total testosterone follows, and free testosterone can stay flat, rise slightly, or fall depending on what drove the SHBG change. So the first question is not how to lower SHBG. It is whether your free or bioavailable testosterone is outside the reference range, and that requires either a good calculation from reliable inputs or a direct measurement by a method that does not itself disturb the binding equilibrium.

Why the two move together

SHBG is synthesized by hepatocytes and its production is regulated largely by hepatic insulin signaling and thyroid hormone. Insulin suppresses SHBG transcription, so insulin resistance and hepatic fat lower it, which is why low SHBG tracks with metabolic syndrome and predicts gestational diabetes well enough to function as an early screening marker 1. First-trimester SHBG has been evaluated in combination with other analytes for the same purpose 2. The inverse holds: lean body composition, good hepatic insulin sensitivity, high thyroid hormone availability, oral estrogen exposure, anticonvulsants, chronic caloric restriction, endurance training volume, and simple genetic variation in the SHBG locus all push SHBG up.

Because total testosterone is a composite of free hormone plus SHBG-bound plus albumin-bound, the total tracks SHBG mechanically. A man with an SHBG of 70 nmol/L and a total testosterone of 900 ng/dL may have exactly the same free testosterone as a man with an SHBG of 30 nmol/L and a total of 550 ng/dL. Interpreting the total in isolation produces two opposite errors: calling the first man androgen-replete when he is not, or calling the second man deficient when he is fine. There is also evidence that SHBG carries information beyond its role as a carrier. In large cohorts of middle-aged and older men, higher SHBG associated with incident fracture risk independently of total testosterone 3, and Mendelian randomization across many phenotypes finds genetically predicted SHBG associated with distinct outcome patterns from testosterone itself 4. Treat SHBG as a biomarker with its own meaning, not only as a denominator.

Getting the numbers right before interpreting them

Most confusion about this pattern comes from bad inputs. Before reasoning about your hormone status, fix the measurement.

Draw between 7 and 10 a.m., fasted, on two separate mornings. Testosterone has a diurnal rhythm with morning peak, and within-person variability from a single draw is large enough to move you across a reference boundary by chance. Insist on liquid chromatography–tandem mass spectrometry (LC-MS/MS) for testosterone rather than a direct immunoassay. Immunoassays are calibrated for mid-range male concentrations and perform badly at the low end and in the presence of cross-reacting steroids, which matters if you are female or on any hormone therapy. For SHBG, immunoassay is standard and acceptable, but note the units: nmol/L, and different labs use different upper limits (commonly 48 to 70 nmol/L for adult men).

Then order the pieces needed for a real free testosterone estimate. You want total testosterone by LC-MS/MS, SHBG, and albumin drawn from the same tube. Do not accept a “free testosterone” from a direct analog immunoassay, which is the cheapest and worst option and correlates poorly with reference methods. Equilibrium dialysis followed by mass spectrometry is the reference standard and is worth the extra cost once, to anchor your calculated values. Ultrafiltration is an acceptable alternative.

For calculation, use a modern binding model rather than the 1999 Vermeulen equation, which assumes a single high-affinity site on SHBG with a fixed association constant. The Zakharov/Jasuja multistep allosteric model fits dialysis measurements better at the extremes of SHBG, which is exactly where you sit if your SHBG is high. Practically: compute free testosterone with both the Vermeulen and the Zakharov models, compare to one dialysis measurement, and then use whichever tracks your dialysis value for longitudinal monitoring. If you are working in code, the inputs are total testosterone in nmol/L (divide ng/dL by 28.84), SHBG in nmol/L, and albumin in g/L, and the output you care about is free testosterone in pmol/L plus percent free.

A high-SHBG man often lands with a total testosterone in the upper quartile, a percent free of 1.0 to 1.4 rather than the typical 2.0 to 2.5, and a calculated free testosterone in the lower half of the reference range. That is a coherent picture and it is not the same as either high or low testosterone. Whether it explains symptoms is a clinical question. Higher SHBG has been associated with androgen deficiency features independently of total testosterone, so symptoms in this setting deserve a clinician’s assessment rather than self-interpretation.

What raises SHBG, and what is worth checking

Rather than reaching for something to lower SHBG, work through the causes that carry their own implications.

Thyroid status comes first. Hyperthyroidism raises SHBG substantially, and thyroxine therapy that overshoots does the same. Check TSH, free T4, and free T3.

Liver status comes second. Both early cirrhosis and, at the other end, very low hepatic fat shift SHBG. Order ALT, AST, GGT, albumin, bilirubin, and platelets. A low platelet count with high SHBG in someone with alcohol exposure or metabolic liver disease is a pattern to bring to a hepatologist.

Energy availability and training load come third. Sustained caloric deficit, low body fat, and high endurance volume raise SHBG and suppress the gonadal axis together. Here the useful accompanying measurements are LH, FSH, free T3, IGF-1, and, if female, estradiol and menstrual history.

Exogenous estrogen and drugs come fourth. Oral estradiol, ethinylestradiol in combined contraceptives, tamoxifen, phenytoin, and carbamazepine all raise SHBG. Transdermal estradiol raises it far less because it bypasses first-pass hepatic exposure.

Genetics comes last and is the one that does not change. Common variants at the SHBG locus, including rs1799941 and the rs6259 (D327N) missense variant, shift both SHBG concentration and its clearance. If you have whole-genome sequencing, pull these directly from your VCF with bcftools view -r on the chr17 region and check the genotypes. A person homozygous for the high-SHBG allele who has a normal calculated free testosterone, normal thyroid, and a clean liver panel has an explained laboratory finding rather than a problem to correct.

Two more considerations belong in a complete picture. Environmental chemical exposures have measurable associations with SHBG and sex steroids in population studies, including phenols and parabens 5 and per- and polyfluoroalkyl substances 6. These are cohort-level associations, not individual diagnostic tools, but they are a reason to log exposures alongside biomarkers if you are building a longitudinal record.

Longitudinal design rather than single-point chasing

The right analytic frame for this pattern is a time series. Set a fixed protocol, run it quarterly, and treat each panel as a point rather than a verdict. Minimum panel: total testosterone by LC-MS/MS, SHBG, albumin, LH, FSH, estradiol by LC-MS/MS, TSH, free T4, free T3, a liver panel, fasting insulin, HbA1c, and hs-CRP. Store results in one table with the assay method and lab recorded per row, because switching labs mid-series introduces step changes that look like biology.

If you also have continuous glucose data, pair it with SHBG. Hepatic insulin exposure is the main modifiable determinant of SHBG, and if your SHBG is falling over months while your mean glucose and glycemic variability are rising, you are watching a metabolic drift rather than a hormone problem. The direction of that relationship is the clearest interpretive handle you have, and it is why we favor measuring the insulin axis alongside the sex steroid axis rather than in isolation.

Anything that involves changing hormone therapy, dosing, or a drug that affects SHBG belongs with an endocrinologist. Bring your time series, the assay methods, and your calculated free testosterone with the dialysis anchor. That is a far better starting point than a single total testosterone number.

Questions people also ask

How can I lower my SHBG? There is no clean answer, and the goal is usually wrong. SHBG falls with increased hepatic insulin exposure, weight gain, and hepatic fat accumulation, none of which anyone should pursue deliberately. If your SHBG is high because of hyperthyroidism, over-replacement of thyroxine, an anticonvulsant, oral estrogen, liver disease, or chronic energy deficit, addressing the cause is the route, and each of those requires a clinician.

Does high SHBG mean high testosterone? It usually means high total testosterone, because the bound fraction is larger. It says nothing reliable about free testosterone, which is what tissues see. Calculate free testosterone from total, SHBG, and albumin, and anchor the calculation once against equilibrium dialysis.

Does SHBG improve with weight loss? SHBG rises with weight loss and improved hepatic insulin sensitivity. That is generally a favorable metabolic direction even though it raises total testosterone and lowers percent free. Interpret the change as metabolic rather than androgenic.

Does SHBG matter on testosterone therapy? Yes, because it changes the relationship between your total testosterone reading and free hormone. Someone with high SHBG can show a mid-range total on therapy with a low free fraction. Monitoring on therapy should include SHBG and a calculated free testosterone rather than total alone, and the same applies to androgen therapy in transgender men, where biochemical markers of androgenization are tracked alongside testosterone levels 7. Dosing decisions belong to the prescribing clinician.

Can high SHBG cause weight gain? High SHBG is more often a marker of leanness and good hepatic insulin sensitivity than of weight gain. If your weight is rising while SHBG is high, look at thyroid status, energy intake, and sleep rather than at SHBG as a cause.

How is high SHBG handled in women? The workup is the same set of causes: thyroid excess, oral estrogen or contraceptive use, liver disease, and low energy availability. In women, SHBG interpretation matters mainly in combination with total and free testosterone and estradiol, and prediagnostic circulating SHBG has been studied in relation to breast outcomes in large cohorts 8. An endocrinologist or gynecologist should interpret the panel in context.

Oak builds longitudinal molecular profiles of individuals: whole-genome sequencing, RNA sequencing, proteomics, blood biomarkers, and continuous glucose data, integrated into one model of you. Build your profile.

Footnotes

  1. Manal Abdalla Tawfeek, Eman Mohamad Alfadhli, Abdulfatah Marawan Alayoubi, et al. Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus. BMC Women’s Health, 2017. https://doi.org/10.1186/s12905-017-0373-3 ↩

  2. Zhijie Li, Peng Yue, Jing Zhao, et al. First-trimester serum SHBG and vaspin as combined biomarkers for predicting gestational diabetes mellitus: a case–control accuracy study. Hormone Molecular Biology and Clinical Investigation, 2026. https://doi.org/10.1515/hmbci-2026-0012 ↩

  3. Louise Grahnemo, Ross J Marriott, Kevin Murray, et al. Associations of Serum Testosterone and SHBG With Incident Fractures in Middle-aged to Older Men. The Journal of Clinical Endocrinology & Metabolism, 2024. https://doi.org/10.1210/clinem/dgae703 ↩

  4. Shuai Yuan, Lijuan Wang, Jing Sun, et al. Genetically predicted sex hormone levels and health outcomes: phenome-wide Mendelian randomization investigation. International Journal of Epidemiology, 2022. https://doi.org/10.1093/ije/dyac036 ↩

  5. Amira M. Aker, Deborah J. Watkins, Lauren E. Johns, et al. Phenols and parabens in relation to reproductive and thyroid hormones in pregnant women. Environmental Research, 2016. https://doi.org/10.1016/j.envres.2016.07.002 ↩

  6. Francesca Romana Mancini, Claire Perrin, Régine Billmann, et al. PFAS internal exposure levels across two generations and endocrine-metabolic biomarker associations in women from the French E3N-Generations cohort. Environment International, 2026. https://doi.org/10.1016/j.envint.2026.110462 ↩

  7. Guillermo Velasco de Cos, María Teresa García Unzueta, Ana Moyano Martínez, et al. Course of Testosterone Levels and Potential Biochemical Biomarkers of Androgenization with a Conservative Protocol of Androgen Hormone Therapy in Transgender Males. Journal of Clinical Medicine, 2026. https://doi.org/10.3390/jcm15166498 ↩

  8. Rhonda S. Arthur, Xiaonan Xue, Thomas E. Rohan. Prediagnostic Circulating Levels of Sex Steroid Hormones and SHBG in Relation to Risk of Ductal Carcinoma In Situ of the Breast among UK Women. Cancer Epidemiology, Biomarkers & Prevention, 2020. https://doi.org/10.1158/1055-9965.epi-19-1302 ↩